C21 BioVentures™ (C21) is the leading conference where early stage innovators, investors and pharma partners come together to do the deals that make 2011 the year of global partnering. With a focus on private companies seeking investors and pharma partners, C21 provides the best early stage opportunities for partnering.
Who should attend?
| |
BIOTECH - C21 puts you at the center of the investment and partnering community and provides an open format to connect with the funding partners you need.
|
INVESTORS - Connect with early stage companies, including up to 70 presenters, and successfully build your investment portfolio in 2011.
|
PHARMA - C21 is highly regarded as the venue to negotiate deals with early stage biotech companies. Don’t miss your opportunity to make a deal with the biotech partner you need to sustain your pipeline.
Numbers are based on average annual attendance |
| |
Participant Summary
